Evidence map›Paper›PMID 24990173›Full record

ArticleTechnology and health care : official journal of the European Society for Engineering and Medicine2014

Acceptability of Global Positioning System technology to survey injecting drug users' movements and social interactions: a pilot study from San Francisco, USA.

A Mirzazadeh, M Grasso, K Johnson, A Briceno, S Navadeh, W McFarland, K Page

Abstract read
In one paragraph

Article in Technology and health care : official journal of the European Society for Engineering and Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A MirzazadehPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA, USA Global Health Sciences, University of California, San Francisco California, San Francisco, CA, USA Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
M GrassoGlobal Health Sciences, University of California, San Francisco California, San Francisco, CA, USA.
K JohnsonGlobal Health Sciences, University of California, San Francisco California, San Francisco, CA, USA.
A BricenoDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
S NavadehGlobal Health Sciences, University of California, San Francisco California, San Francisco, CA, USA Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
W McFarlandGlobal Health Sciences, University of California, San Francisco California, San Francisco, CA, USA.
K PageGlobal Health Sciences, University of California, San Francisco California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
Acute Hepatitis C Infection in Young InjectorsR01DA016017 · NIDA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAGE, KIMBERLY · 2002 to 2018
$14.0M
NCRR NIH HHS UL1 RR024131NIDA NIH HHS R01 DA016017NIDA NIH HHS R01DA016017NIDDK NIH HHS P30 DK026743NIMH NIH HHS P30 MH062246NIMH NIH HHS P30MH062246
6 · The paper itself

Abstract

backgroundDespite potential applications for improving health services using GPS technology, little is known about ethical concerns, acceptability, and logistical barriers for their use, particularly among marginalized groups.

objectivesWe garnered the insights of people who inject drug (PWID) in San Francisco on these topics.

methodsPWID were enrolled through street-outreach (n=20) and an ongoing study (n=4) for 4 focus group discussions. Participants also completed a self-administered questionnaire on demographic characteristics and their numbers and types of interactions with other PWID.

resultsMedian age was 30.5 years, majorities were male (83.3%) and white (68.2%). Most interacted with other PWID for eating meals and purchasing drugs over the last week; fewer reported interactions such as sexual contact, drug treatment, or work. Participants identified several concerns about carrying GPS devices, including what authorities might do with the data, that other PWID and dealers may suspect them as informants, and adherence to carrying and use. Most felt concerns were surmountable with detailed informed consent on the purpose of the study and practical ways to carry, charge, and hide devices.

conclusionsPWID felt data collection on their movements and social interactions with other PWID using GPS can be acceptable with addressing specific concerns. The technology is now in hand to greatly expand the ability to monitor health conditions with respect to the environment and improve the location of prevention, care, and treatment facilities to serve hard to reach, mobile, and hidden populations.

Indexed as

Interpersonal RelationsAdultConfidentialityData CollectionDrug UsersFemaleFocus GroupsGeographic Information SystemsHumansMaleMiddle AgedPilot ProjectsSan FranciscoSocioeconomic FactorsSubstance Abuse, Intravenousacceptabilitydata collectionGPS technologypeople who inject drugs

Identifiers

PMID24990173
PMCPMC4511082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.